BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 9816017)

  • 1. Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.
    Molthoff CF; Pinedo HM; Schlüper HM; Boven E
    Cancer Immunol Immunother; 1991; 34(3):191-7. PubMed ID: 1756536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene.
    Li Y; Liu D; Chen D; Kharbanda S; Kufe D
    Oncogene; 2003 Sep; 22(38):6107-10. PubMed ID: 12955090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation Changes in Brain Cancer.
    Veillon L; Fakih C; Abou-El-Hassan H; Kobeissy F; Mechref Y
    ACS Chem Neurosci; 2018 Jan; 9(1):51-72. PubMed ID: 28982002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells.
    Bernal SD; Ona ET; Riego-Javier A; DE Villa R; Cristal-Luna GR; Laguatan JB; Batac ER; Canlas OQ
    Oncol Lett; 2012 Jan; 3(1):66-74. PubMed ID: 22740858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucins in cancer: function, prognosis and therapy.
    Kufe DW
    Nat Rev Cancer; 2009 Dec; 9(12):874-85. PubMed ID: 19935676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope.
    Perey L; Hayes DF; Kufe D
    Cancer Res; 1992 Nov; 52(22):6365-70. PubMed ID: 1384960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
    Burton J; Mishina D; Cardillo T; Lew K; Rubin A; Goldenberg DM; Gold DV
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3065s-3072s. PubMed ID: 10541345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a family of high molecular weight tumor-associated glycoproteins.
    Abe M; Kufe DW
    J Immunol; 1987 Jul; 139(1):257-61. PubMed ID: 2438351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.
    Perey L; Hayes DF; Maimonis P; Abe M; O'Hara C; Kufe DW
    Cancer Res; 1992 May; 52(9):2563-8. PubMed ID: 1373671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the DF3-P epitope in human ovarian carcinomas.
    Ichige K; Perey L; Vogel CA; Buchegger F; Kufe D
    Clin Cancer Res; 1995 May; 1(5):565-71. PubMed ID: 9816017
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.